Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: A prognostic marker for responses to interferon treatment.
about
Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patientsPlatelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis.The use of whey protein concentrate in management of chronic hepatitis C virus - a pilot study.Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C.Interferon-alpha inhibits airway eosinophilia and hyperresponsiveness in an animal asthma model [corrected]Infectious burden and atherosclerosis: A clinical issue.Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis.Relationship between adhesion molecules and virological response to pegylated interferon-alpha-2a treatment in patients with chronic hepatitis B: A pilot study.Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
P2860
Q28344148-FC353B43-D85B-49CF-92AF-60A6ECE9C507Q33349456-BED3E417-CA63-4747-BAEC-59C5F660D783Q35817765-29891FF6-DBFE-4A3F-8702-65E036D9D9F0Q36180397-B7D7574D-2F5D-4D05-931D-2EA9BF1BBF97Q36365177-00B7B634-93AC-42DE-A898-C33F3D4FA012Q37843968-FAC90A23-B41E-49F7-AC98-2BD4CAE38862Q38787424-CCA458BC-258A-4633-84E3-8382D7B6F7F9Q42244578-6492ED64-182A-4555-9B8E-71AE3D5ED79FQ43035003-2A8890C0-16BD-4AA3-BD55-595453D70F86
P2860
Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: A prognostic marker for responses to interferon treatment.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Serum level of soluble interce ...... onses to interferon treatment.
@en
Serum level of soluble interce ...... onses to interferon treatment.
@nl
type
label
Serum level of soluble interce ...... onses to interferon treatment.
@en
Serum level of soluble interce ...... onses to interferon treatment.
@nl
prefLabel
Serum level of soluble interce ...... onses to interferon treatment.
@en
Serum level of soluble interce ...... onses to interferon treatment.
@nl
P2093
P356
P1476
Serum level of soluble interce ...... onses to interferon treatment.
@en
P2093
E De Maria
G B Gabrielli
L Marchiori
P Mezzelani
P304
P356
10.1086/315265
P407
P577
2000-02-01T00:00:00Z